Imugene shares soar on US breast cancer trial
MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning after gaining
MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning after gaining